Pharmafile Logo
Pharmafocus logo
Advanced Search
Xarelto

Bayer backs safety of Xarelto after real-world data study

September 2, 2015
Research and Development Bayer, ESC, European Society of Cardiology, Xarelto, anticoagulants, atrial fibrillation, real-word evidence, rivaroxaban

Around 96 in every 100 people treated with Bayer’s anticoagulant Xarelto do not experience any major bleeding, related side effects …

News
google logo

Sanofi joins Google in diabetes tech push

September 1, 2015
Medical Communications Andy Conrad, Google life sciences, Sanofi, Type 1 diabetes, diabetes, google, type 2 diabetes

Google is continuing its work in diabetes, by teaming up with pharma giants Sanofi to create new digital technologies and …

News
scales

Standardising the pharma benefit-risk assessment process

September 1, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, FDA, benefit-risk analysis, pharmacoepidemiology, pharmacovigilance

Over the past decade, pharmaceutical companies and regulatory agencies have been reviewing the benefit-risk assessment of medicines with a view …

Feature
Alexion sign

Alexion scores double EU approval

September 1, 2015
Manufacturing and Production, Sales and Marketing Alexion, EC, European Commission, Kanuma, Strensiq, asfotase alfa, sebelipase alfa, ultra rare disease, ultra-rare disease

Two treatments developed by ultra-rare disease specialists Alexion Pharmaceuticals are now approved for use in Europe. The European Commission approved …

News

Bristol-Myers Squibb makes big pharma deals

September 1, 2015
Manufacturing and Production BMS, Bristol-Myers Squibb, PRM-151, Promedior, QIMR, fibrosis, idiopathic pulmonary fibrosis, immuno-oncology, myelofibrosis

Bristol-Myers Squibb is flexing its muscles in respiratory disease, by signing a deal to acquire the exclusive right to acquire …

News
FDA sign

FDA issues gliptin joint pain warning

September 1, 2015
Manufacturing and Production DPP-4 inhibitors, ESC, FDA, TECOS, adverse effects, drug safety, gliptins, safety alert, safety warning

The FDA has issued a safety alert, warning of joint pain caused by the gliptins, a common class of drugs …

News
mytrus_cartoon

NHS approves electronic consent technology in clinical trials

August 28, 2015
Medical Communications, Research and Development Mytrus, NHS, clinical trials, digital health technology, electronic informed consent

Clinical technology and services company Mytrus has announced that its software platform for electronic informed consent has received approval for …

News
boehringer_lilly

New Boehringer and Lilly type 2 diabetes treatment gets FDA nod

August 28, 2015
Research and Development, Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, Synjardy, type 2 diabetes

The FDA has approved Synjardy, from Boehringer Ingelheim and Eli Lilly, for the treatment of adults with type 2 diabetes. …

News

FDA approves Amgen’s cholesterol lowering drug

August 28, 2015
Medical Communications, Research and Development Amgen, FDA, Repatha, evolocumab

The FDA has endorsed Amgen’s cholesterol-lowering medication, Repatha, for the use in patients with high cholesterol. It follows Amgen’s successful …

News
Sanofi's go meals app

Moves in pharma app market, but user longevity an issue

August 28, 2015
Medical Communications Communication, apps, digital, medcomms, medical communications, mobile

Pharma companies continue to invest in the mobile app market, but studies have found that pharma apps suffer the same …

News
ESC congress sign

NHS looks to ESC for next-gen heart drug data

August 28, 2015
Medical Communications, Research and Development ALN-PCScs, Repatha, alirocumab, cardiology, cardiovascular disease, cvd, evolocumab, heart disease, high cholesterol, praluent

New data is expected to be presented at the European Cardiology Society congress in London, on the high cholesterol drugs …

News

Novo Nordisk to buy two pharma research companies

August 27, 2015
Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, mergers and acquisitions

Novo Nordisk is to acquire two privately-held biopharmaceutical research companies specialising in diabetes, for undisclosed sums. Calibrium and MB2, formed …

News
st_judes_ensite_precision_mapping_module

Abbott to table $25bn bid for medical device maker St Jude?

August 27, 2015
Manufacturing and Production, Sales and Marketing Abbott Laboratories, mergers and acquisitions, st jude medical

Abbott Laboratories is said to be preparing a $25 billion takeover bid for medical device maker St Jude Medical.  Illinois-based Abbott …

News

Cally Clarkson joins GCI Health as first director of medical education

August 27, 2015
Medical Communications Cally Clarkson, GCI Health

GCI Health has appointed Cally Clarkson as its first ever director of medical education.  Cally is based in GCI Health’s …

Appointment

Vicky Smith promoted to senior account executive at Liberation Unlimited

August 27, 2015
Medical Communications Vicki Smith, liberation unlimited

Liberation Unlimited has promoted Vicky Smith to senior account executive.Vicky joined Liberation Unlimited in 2013, and has since played an …

Appointment
alvogen_drugs_generic

Alvogen buys four-drug portfolio from Pfizer

August 27, 2015
Sales and Marketing Alvogen, Pfizer

Alvogen has entered into a agreement with Pfizer to purchase a portfolio of four pharmaceutical products for the US market, …

News
cml

NHS restriction of CML treatment in England criticised

August 27, 2015
Medical Communications, Sales and Marketing NHS, NICE, chronic myeloid leukaemia, leukaemia

Medical experts have criticised NHS cost regulators’ decision to limit the use of Ariad’s Iclusig (ponatinib) in the treatment of …

News
md_anderson_cancer_center

Immatics and MD Anderson launch new company to develop ACR therapies

August 27, 2015
Research and Development, Sales and Marketing Cancer, MD Anderson Cancer Center, immatics, keytruda

Immatics Biotechnologies and The University of Texas MD Anderson Cancer Center (MDACC) have together launched a new company focusing on …

News
diabetes_injection

NICE targets tight blood sugar control in new diabetes guidelines

August 27, 2015
NICE, NICE guidelines, Public Health England, Type 1 diabetes, diabetes

NICE has urged healthcare professionals to target tighter blood sugar control, in a suite of recommendation in updated guidelines on …

News
alimta

Lilly defeats Teva in US court over Alimta patent

August 26, 2015
Research and Development, Sales and Marketing Alimta, Eli Lilly, Teva Pharmaceutical, lung cancer

Eli Lilly has won a case in a US federal court, in a battle over Teva’s attempt to create a …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026